[1] ROJAS M, CHÁVEZ-CASTILLO M, PIRELA D, et al. Metabolic Syndrome: Is It Time to Add the Central Nervous System? Nutrients. 2021;13(7):2254.
[2] ECKEL RH, GRUNDY SM, ZIMMET PZ. The metabolic syndrome. Lancet. 2005;365 (9468):1415-1428.
[3] WILSON PW, D’AGOSTINO RB, PARISE H,
et al. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005;112(20):3066-3072.
[4] WEN Q, ZHAO Z, WEN J, et al. Impact of obesity on operative complications and outcome after sacrocolpopexy: A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2021;258:309-316.
[5] LJUNGQVIST O. Insulin resistance and outcomes in surgery. J Clin Endocrinol Metab. 2010;95(9):4217-4219.
[6] CROWTHER M, VAN DER SPUY K, ROODT F, et al. The relationship between pre-operative hypertension and intra-operative haemodynamic changes known to be associated with postoperative morbidity. Anaesthesia. 2018;73(7):812-818.
[7] FEINKOHL I, WINTERER G, PISCHON T. Associations of dyslipidaemia and lipid-lowering treatment with risk of postoperative cognitive dysfunction: a systematic review and meta-analysis. J Epidemiol Community Health. 2018;72(6): 499-506.
[8] BHAYANI NH, HYDER O, FREDERICK W, et al. Effect of metabolic syndrome on perioperative outcomes after liver surgery: A National Surgical Quality Improvement Program (NSQIP) analysis. Surgery. 2012; 152(2):218-226.
[9] PASSIAS PG, BROWN AE, LEBOVIC J, et al. Metabolic Syndrome has a Negative Impact on Cost Utility Following Spine Surgery. World Neurosurg. 2020;135:e500-e504.
[10] GUOFENG C, CHEN Y, RONG W, et al. Patients with metabolic syndrome have a greater rate of complications after arthroplasty: A systematic review and meta-analysis. Bone Joint Res. 2020;9(3):120-129.
[11] GLANCE LG, WISSLER R, MUKAMEL DB,
et al. Perioperative outcomes among patients with the modified metabolic syndrome who are undergoing noncardiac surgery. Anesthesiology. 2010;113(4):859-872.
[12] JOHNSTON SS, FORTIN SP, PRACYK JB, et al. Economic and clinical outcomes of spinal fusion surgeries with skin closure through skin staples plus waterproof wound dressings versus 2-octyl cyanoacrylate plus polymer mesh tape. Spine J. 2021;21(1): 45-54.
[13] CHUNG AS, CAMPBELL D, WALDROP R, et al. Metabolic Syndrome and 30-Day Outcomes in Elective Lumbar Spinal Fusion. Spine (Phila Pa 1976). 2018;43(9):661-666.
[14] HE X, FEI Q, SUN T. Metabolic syndrome increases risk for perioperative outcomes following posterior lumbar interbody fusion. Medicine (Baltimore). 2020;99(38): e21786.
[15] YE IB, TANG R, SCHWARTZ JT, et al. Postoperative Complications Associated With Metabolic Syndrome Following Adult Spinal Deformity Surgery. Clin Spine Surg. 2020;33(2):E87-E91.
[16] PIERCE KE, KAPADIA BH, BORTZ C, et al. Operative fusion of patients with metabolic syndrome increases risk for perioperative complications. J Clin Neurosci. 2020;72: 142-145.
[17] LOVECCHIO F, FU MC, IYER S, et al. Does Obesity Explain the Effect of the Metabolic Syndrome on Complications Following Elective Lumbar Fusion? A Propensity Score Matched Analysis. Global Spine J. 2018; 8(7):683-689.
[18] MALIK AT, JAIN N, KIM J, et al. The Impact of Metabolic Syndrome on 30-Day Outcomes Following Elective Anterior Cervical Discectomy and Fusions. Spine (Phila Pa 1976).2019;44(5):E282-E287.
[19] MEMTSOUDIS SG, KIRKSEY M, MA Y, et al. Metabolic syndrome and lumbar spine fusion surgery: epidemiology and perioperative outcomes. Spine (Phila Pa 1976). 2012;37(11):989-995.
[20] SELPH JP, WHITED WM, SMITH AB, et al. Metabolic syndrome as a predictor for postoperative complications after urologic surgery. Urology. 2014;83(5):1051-1059.
[21] GONZALEZ DELLA VALLE A, CHIU Y L, MA Y, et al. The metabolic syndrome in patients undergoing knee and hip arthroplasty: trends and in-hospital outcomes in the United States. J Arthroplasty. 2012;27(10): 1743-1749.e1.
[22] TILG H, MOSCHEN AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol. 2006;6(10):772-783.
[23] FALAGAS ME, KOMPOTI M. Obesity and infection. Lancet Infect Dis. 2006;6(7): 438-446.
[24] MCCRACKEN E, MONAGHAN M, SREENIVASAN S. Pathophysiology of the metabolic syndrome. Clin Dermatol. 2018; 36(1):14-20.
[25] STORTZ JA, COX MC, HAWKINS RB,
et al. Phenotypic heterogeneity by site of infection in surgical sepsis: a prospective longitudinal study. Crit Care. 2020;24(1): 203.
[26] DEVARAJ S, VALLEGGI S, SIEGEL D, et al. Role of C-reactive protein in contributing to increased cardiovascular risk in metabolic syndrome. Curr Atheroscler Rep. 2010; 12(2):110-118.
[27] EDELSTEIN AI, SULEIMAN LI, ALVAREZ AP, et al. The Interaction of Obesity and Metabolic Syndrome in Determining Risk of Complication Following Total Joint Arthroplasty. J Arthroplasty. 2016;31(9 Suppl): 192-196.
[28] ZMISTOWSKI B, DIZDAREVIC I, JACOVIDES CL, et al. Patients with uncontrolled components of metabolic syndrome have increased risk of complications following total joint arthroplasty . J Arthroplasty. 2013;28(6):904-907.
[29] ANDERSEN CJ, MURPHY KE, FERNANDEZ ML. Impact of Obesity and Metabolic Syndrome on Immunity. Adv Nutr. 2016; 7(1):66-75.
[30] SCULLY IL, MCNEIL LK, PATHIRANA S,
et al. Neutrophil killing of Staphylococcus aureus in diabetes, obesity and metabolic syndrome: a prospective cellular surveillance study. Diabetol Metab Syndr. 2017;9:76.
[31] HEDSTROM M, LJUNGQVIST O, CEDERHOLM T. Metabolism and catabolism in hip fracture patients: nutritional and anabolic intervention--a review. Acta Orthop. 2006;77(5):741-747.
[32] GONZALEZ-CHÁVEZ A, CHÁVEZ-FERNÁNDEZ JA, ELIZONDO-ARGUETA S, et al. Metabolic Syndrome and Cardiovascular Disease: A Health Challenge. Arch Med Res. 2018; 49(8):516-521.
[33] KHAING P, PANDIT P, AWSARE B, et al. Pulmonary Circulation in Obesity, Diabetes, and Metabolic Syndrome. Compr Physiol. 2019;10(1):297-316.
[34] CHAPLIN A, CARPÉNÉ C, MERCADER J. Resveratrol, Metabolic Syndrome, and Gut Microbiota. Nutrients. 2018;10(11):1651.
[35] DI NISIO M, VAN ES N, BÜLLER HR. Deep vein thrombosis and pulmonary embolism. Lancet. 2016;388(10063):3060-3073.
[36] SONG K, RONG Z, YAO Y, et al. Metabolic Syndrome and Deep Vein Thrombosis After Total Knee and Hip Arthroplasty. J Arthroplasty. 2016;31(6):1322-1325.
[37] AY C, TENGLER T, VORMITTAG R, et al. Venous thromboembolism--a manifestation of the metabolic syndrome. Haematologica. 2007;92(3):374-380.
[38] DY CJ, WILKINSON JD, TAMARIZ L, et al. Influence of preoperative cardiovascular risk factor clusters on complications of total joint arthroplasty. Am J Orthop (Belle Mead NJ). 2011;40(11):560-565. |